The Journal of Practical Medicine ›› 2026, Vol. 42 ›› Issue (2): 311-319.doi: 10.3969/j.issn.1006-5725.2026.02.017
• Feature Reports:Orthopedics • Previous Articles
Yanhong JIANG1,Yiyin XU1,Ruotong LIAO1,Lijun WEI1,Xuewei CAO2,Minqing LI3,Jinhui LIAO1,Jiajie HUANG4,Xingli CHEN1(
)
Received:2025-09-01
Revised:2025-11-14
Accepted:2025-11-27
Online:2026-01-25
Published:2026-01-22
Contact:
Xingli CHEN
E-mail:420497017@qq.com
CLC Number:
Yanhong JIANG,Yiyin XU,Ruotong LIAO,Lijun WEI,Xuewei CAO,Minqing LI,Jinhui LIAO,Jiajie HUANG,Xingli CHEN. An empirical study on the impact of single-dose and multiple-dose antibiotic regimens on nursing workload and medical costs in total joint arthroplasty: A nursing-led systematic review[J]. The Journal of Practical Medicine, 2026, 42(2): 311-319.
Tab.1
Comparison of two groups of general data"
| 项目 | 单次组(n = 972) | 多次组(n = 976) | t/χ2值 | P值 |
|---|---|---|---|---|
| 年龄/岁 | 67.50 ± 9.551 | 67.97 ± 9.104 | -1.125 | 0.261 |
| 住院时间/d | 7.33 ± 3.021 | 7.22 ± 2.813 | 0.800 | 0.424 |
| BMI/(kg/m2) | 25.655 ± 3.734 | 25.437 ± 3.676 | 1.300 | 0.194 |
| 性别/例 | 1.182 | 0.277 | ||
| 女 | 748 | 771 | ||
| 男 | 224 | 205 | ||
| 糖尿病史/例 | 0.173 | 0.678 | ||
| 合并 | 836 | 833 | ||
| 未合并 | 136 | 14 | ||
| 吸烟史/例 | 0.464 | 0.486 | ||
| 有 | 24 | 29 | ||
| 无 | 948 | 947 | ||
| 出院血白蛋白计量/例 | 0.308 | 0.579 | ||
| > 35 g/L | 72 | 66 | ||
| < 35 g/L | 900 | 910 |
Tab.2
Comparison of baseline characteristics between the two groups in cefuroxime sodium subgroup after primary hip arthroplasty"
| 因素 | 多次组(n = 24) | 单次组(n = 20) | t/χ2/Z值 | P值 |
|---|---|---|---|---|
| 年龄/岁 | 64.04 ± 14.669 | 56.65 ± 14.280 | 1.684 | 0.100 |
| 性别(女)/例 | 17 | 11 | 1.182 | 0.277 |
| 胸片肺部炎症(阴性)/例 | 22 | 16 | 1.261 | 0.264 |
| 尿WBC阳性/例 | 5 | 3 | 0.178 | 0.673 |
| 合并患糖尿病/例 | 20 | 16 | 0.081 | 0.775 |
| 术前Hb/(g/L) | 128.96 ± 10.768 | 133.30 ± 14.729 | -1.128 | 0.266 |
| 术后3 h Hb | 108.88 ± 11.987 | 114.60 ± 17.893 | -1.265 | 0.213 |
| 术后第1天Hb | 106.04 ± 10.411 | 110.65 ± 16.259 | -1.094 | 0.282 |
| 出院前Hb | 99.006 ± 14.197 | 104.790 ± 16.471 | -1.251 | 0.218 |
| 入院白蛋白/(g/L) | 42.892 ± 4.538 | 43.175 ± 5.157 | 0.194 | 0.847 |
| 术后第1天白蛋白/(g/L) | 35.514 ± 4.505 | 35.535 ± 4.634 | -0.015 | 0.988 |
| 术后第3天白蛋白/(g/L) | 36.181 ± 3.019 | 36.749 ± 3.083 | -0.616 | 0.541 |
| 术前WBC[M(P25,P75)]/( | 6.46(5.47,7.70) | 6.29(5.29, 7.83) | -0.165 | 0.869 |
| 术前中性粒细胞计数[M(P25,P75)]/( | 4.44(3.50, 5.28) | 3.82(3.16,4.98) | -0.943 | 0.346 |
| 术前CRP[M(P25,P75)]/(mg/L) | 5.31(1.91, 13.37) | 6.99(1.71, 10.00) | -0.472 | 0.637 |
| 术前ESR[M(P25,P75)] | 37(25.25,51.75) | 34.5(26.25, 54.25) | -0.177 | 0.860 |
Tab.3
Comparison of general data between the two groups in cefazolin sodium subgroup after primary knee arthroplasty"
| 因素 | 多次组(n = 68) | 单次组(n = 62) | t/χ2/Z值 | P值 |
|---|---|---|---|---|
| 年龄/岁 | 67.49±7.735 | 68.26±6.191 | -0.625 | 0.533 |
| 性别(女)/例 | 55 | 55 | 1.526 | 0.217 |
| 胸片肺部炎症(阴性)/例 | 61 | 36 | 17.142 | 0.001 |
| 尿WBC阳性/例 | 16 | 22 | 2.240 | 0.134 |
| 合并患糖尿病/例 | 52 | 42 | 1.234 | 0.267 |
| 术前Hb/(g/L) | 130.19±12.096 | 129.1±12.010 | 0.487 | 0.627 |
| 术后3 h Hb | 121.57±13.931 | 118.4±11.315 | 1.380 | 0.170 |
| 术后第1天Hb | 124.24±12.741 | 120.3±12.187 | 1.793 | 0.075 |
| 出院前Hb | 114.29±11.101 | 112.2±11.470 | 1.044 | 0.299 |
| 入院白蛋白/(g/L) | 44.274±2.898 | 44.055±3.257 | 0.405 | 0.686 |
| 术后第1天白蛋白/(g/L) | 39.831±3.000 | 39.504±3.074 | 0.615 | 0.540 |
| 术后第3天白蛋白/(g/L) | 38.469±2.584 | 38.537±2.961 | -0.139 | 0.890 |
| 术前WBC[M(P25,P75)]/( | 6.47(5.63, 7.49) | 7.00(5.66, 8.29) | -1.412 | 0.158 |
| 术前中性粒细胞计数[M(P25,P75)]/( | 4.10(3.28, 4.96) | 4.47(3.41, 5.74) | -1.305 | 0.192 |
| 术前CRP[M(P25,P75)]/(mg/L) | 2.35(0.84, 6.08) | 6.60(1.81, 10.07) | -3558 | 0.001 |
| 术前ESR[M(P25,P75)] | 31(22.25, 48.00) | 32.5(21.00, 39.50) | 0.718 | 0.473 |
Tab.4
Comparison of baseline characteristics betweenthe two groups in cefuroxime sodium subgroup after primary knee arthroplasty"
| 因素 | 多次组(n = 61) | 单次组(n = 68) | t/χ2/Z值 | P值 |
|---|---|---|---|---|
| 年龄/岁 | 67.70 ± 10.918 | 69.59 ± 6.447 | -1.207 | 0.230 |
| 性别(女)/例 | 54 | 62 | 0.250 | 0.617 |
| 胸片肺部炎症(阴性)/例 | 57 | 50 | 9.014 | 0.003 |
| 尿WBC阳性/例 | 20 | 20 | 0.171 | 0.679 |
| 合并患糖尿病/例 | 39 | 38 | 0.866 | 0.352 |
| 术前Hb/(g/L) | 131.48 ± 11.088 | 129.10 ± 12.370 | 1.142 | 0.256 |
| 术后3 h Hb | 119.85 ± 11.347 | 119.68 ± 11.932 | 0.086 | 0.932 |
| 术后第1天Hb | 121.80 ± 12.243 | 121.26 ± 12.882 | 0.243 | 0.809 |
| 出院前Hb | 114.827 ± 11.576 | 114.526 ± 11.986 | 0.145 | 0.885 |
| 入院白蛋白/(g/L) | 44.474 ± 5.040 | 44.382 ± 3.083 | 0.126 | 0.900 |
| 术后第1天白蛋白/(g/L) | 39.441 ± 4.176 | 39.708 ± 2.891 | -0.426 | 0.671 |
| 术后第3天白蛋白/(g/L) | 38.749 ± 3.309 | 38.490 ± 3.091 | 0.478 | 0.633 |
| 术前WBC[M(P25,P75)]/( | 6.37(5.36, 7.70) | 6.38(5.60,7.84) | -0.365 | 0.715 |
| 术前中性粒细胞计数[M(P25,P75)]/( | 4.38(3.56, 5.20) | 4.07(3.43, 5.12) | -1.076 | 0.282 |
| 术前CRP[M(P25,P75)]/(mg/L) | 3.61(1.29, 6.16) | 5.75(1.75, 10.00) | -1.798 | 0.072 |
| 术前ESR[M(P25,P75)] | 40.00(22.00,64.00) | 27.00(20.00,38.00) | -2.938 | 0.003 |
| [1] |
刘建, 高勇, 李红, 等. 可溶性尿激酶型纤溶酶原激活物受体对人工关节感染的诊断价值[J]. 实用医学杂志, 2018, 34(10): 1693-1697. doi:10.3969/j.issn.1006-5725.2018.10.029 .
doi: 10.3969/j.issn.1006-5725.2018.10.029 |
| [2] |
郭昶志, 孙涛, 韩殊曼, 等. 膝关节肿瘤假体发生周围感染的危险因素分析及血清D-二聚体、Toll样受体2的预测价值[J]. 实用医学杂志, 2024, 40(6): 814-819. doi:10.3969/j.issn. 1006-5725.2024.06.014 .
doi: 10.3969/j.issn. 1006-5725.2024.06.014 |
| [3] |
BERBERICH C, JOSSE J, RUIZ P S. Patients at a high risk of PJI: Can we reduce the incidence of infection using dual antibiotic-loaded bone cement?[J]. Arthroplasty, 2022, 4(1): 41. doi:10.1186/s42836-022-00142-7 .
doi: 10.1186/s42836-022-00142-7 |
| [4] |
VELTMAN E S, LENGUERRAND E, MOOJEN D J F, et al. Similar risk of complete revision for infection with single-dose versus multiple-dose antibiotic prophylaxis in primary arthroplasty of the hip and knee: Results of an observational cohort study in the Dutch Arthroplasty Register in 242, 179 patients[J]. Acta Orthop, 2020, 91(6): 794-800. doi:10.1080/17453674.2020. 1794096 .
doi: 10.1080/17453674.2020. 1794096 |
| [5] |
FERNANDES A, PARK J Y, LEIBOVITCH L, et al. Single-dose versus extended antibiotic prophylaxis in primary hip and knee arthroplasty: A systematic review and meta-analysis[J]. Cureus, 2024, 16(11): e74049. doi:10.7759/cureus.74049 .
doi: 10.7759/cureus.74049 |
| [6] |
CLASSEN D C, EVANS R S, PESTOTNIK S L, et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection[J]. N Engl J Med, 1992, 326(5): 281-286. doi:10.1056/NEJM199201303260501 .
doi: 10.1056/NEJM199201303260501 |
| [7] |
李月, 王建设. 2016—2018年南京市儿童医院小儿Ⅰ类切口手术围手术期抗菌药物使用合理性分析[J]. 现代药物与临床, 2020, 35(2): 345-348. doi:10.7501/j.issn.1674-5515. 2020.02.032 .
doi: 10.7501/j.issn.1674-5515. 2020.02.032 |
| [8] |
乔进, 赵彦, 陈霞, 等. 2017—2019年临床药师持续干预骨科清洁手术预防性使用抗菌药物的效果分析[J]. 检验医学与临床, 2021, 18(4): 506-509. doi:10.3969/j.issn.1672-9455.2021. 04.022 .
doi: 10.3969/j.issn.1672-9455.2021. 04.022 |
| [9] |
杨延良, 王顺利, 史炎鑫. 骨科清洁手术预防使用抗菌药物与术后感染的关系[J]. 临床骨科杂志, 2017, 20(4): 469-472. doi:10.3969/j.issn.1008-0287.2017.04.030 .
doi: 10.3969/j.issn.1008-0287.2017.04.030 |
| [10] |
罗瑶, 方心俞. 单髁置换术后假体周围感染预防中国专家共识[J]. 实用骨科杂志, 2025, 31(1): 1-14. doi:10.13795/j.cnki.sgkz.2025.01.013 .
doi: 10.13795/j.cnki.sgkz.2025.01.013 |
| [11] |
TAN T L, SHOHAT N, RONDON A J, et al. Perioperative antibiotic prophylaxis in total joint arthroplasty: A single dose is as effective as multiple doses[J]. J Bone Joint Surg Am, 2019, 101(5): 429-437. doi:10.2106/JBJS.18.00336 .
doi: 10.2106/JBJS.18.00336 |
| [12] |
CHRISTENSEN D D, MOSCHETTI W E, BROWN M G, et al. Perioperative antibiotic prophylaxis: Single and 24-hour antibiotic dosages are equally effective at preventing periprosthetic joint infection in total joint arthroplasty[J]. J Arthroplasty, 2021, 36(7S): S308-S313. doi:10.1016/j.arth.2021.02.037 .
doi: 10.1016/j.arth.2021.02.037 |
| [13] |
WYMENGA A, VAN HORN J, THEEUWES A, et al. Cefuroxime for prevention of postoperative coxitis. One versus three doses tested in a randomized multicenter study of 2, 651 arthroplasties[J]. Acta Orthop Scand, 1992, 63(1): 19-24. doi:10.3109/17453679209154842 .
doi: 10.3109/17453679209154842 |
| [14] |
NUSRATH S, NAIR A, DASU S, et al. Single-dose prophylactic antibiotic versus extended usage for four days in clean-contaminated oncological surgeries: A randomized clinical trial[J]. Indian J Surg Oncol, 2020, 11(3): 378-386. doi:10.1007/s13193-020-01163-x .
doi: 10.1007/s13193-020-01163-x |
| [15] |
BRATZLER D W, DELLINGER E P, OLSEN K M, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery[J]. Am J Health Syst Pharm, 2013, 70(3): 195-283. doi:10.2146/ajhp120568 .
doi: 10.2146/ajhp120568 |
| [16] |
World Health Organization. Global guidelines for the prevention of surgical site infection, 2nd ed.[EB/OL]. (2018). . doi:10.1016/j.jhin.2016.12.016
doi: 10.1016/j.jhin.2016.12.016 |
| [17] |
GUNTIN J, SERINO J, ROSSI D, et al. Hypoalbuminemia increases mortality after two-stage revision total joint arthroplasty[J]. Arch Bone Jt Surg, 2023, 11(3): 173-179. doi:10.22038/ABJS.2022.65148.3123 .
doi: 10.22038/ABJS.2022.65148.3123 |
| [18] |
SHIKDAR Y A, MOSLI H H, SHIKDAR N A, et al. Diabetes mellitus and related admission factors among hospitalized patients in king abdul-aziz university hospital in Jeddah, Saudi Arabia[J]. Cureus, 2022, 14(5): e25312. doi:10.7759/cureus.25312 .
doi: 10.7759/cureus.25312 |
| [19] |
WANG L, LU H, DONG X, et al. The effect of nurse staffing on patient-safety outcomes: A cross-sectional survey[J]. J Nurs Manag, 2020, 28(7): 1758-1766. doi:10.1111/jonm.13138 .
doi: 10.1111/jonm.13138 |
| [20] |
WANG L, CHEN H, WAN Q, et al. Effects of self-rated workload and nurse staffing on work engagement among nurses: A cross-sectional survey[J]. J Nurs Manag, 2021, 29(5): 1329-1337. doi:10.1111/jonm.13274 .
doi: 10.1111/jonm.13274 |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||

